Trevi Therapeutics Inc Ph2 CANAL Interim Analysis Conference Call Transcript
Good morning, and welcome to the Trevi Therapeutics Phase II CANAL Interim Analysis Conference Call of Haduvio for the treatment of Chronic Cough in IPF. (Operator Instructions) Please note this event may be recorded.
Various remarks that management may make during this call about the company's future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of the company's most recent reported quarterly report on Form 10-Q for the quarter ended September 30, 2021. In addition, any forward-looking statements represent the company's views only as of today and should not be relied upon as representing the company's views as any subsequent date. While the company may elect to update these forward-looking statements at some point in the future, the company specifically disclaims any obligation to do
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
